RJFSA
TMO icon

Raymond James Financial Services Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Raymond James Financial Services Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$53.3M Sell
86,208
-5,849
-6% -$3.46M 0.07% 265
2024
Q2 		$50.9M Buy
92,057
+2,591
+3% +$1.48M 0.07% 252
2024
Q1 		$52M Buy
89,466
+3,518
+4% +$1.97M 0.08% 243
2023
Q4 		$45.6M Buy
85,948
+3,258
+4% +$1.58M 0.07% 252
2023
Q3 		$41.9M Buy
82,690
+997
+1% +$531K 0.08% 253
2023
Q2 		$42.6M Buy
81,693
+306
+0.4% +$165K 0.08% 250
2023
Q1 		$46.9M Sell
81,387
-2,033
-2% -$1.15M 0.09% 223
2022
Q4 		$46M Sell
83,420
-8,624
-9% -$4.57M 0.09% 217
2022
Q3 		$46.7M Buy
92,044
+144
+0.2% +$80.6K 0.1% 196
2022
Q2 		$50M Sell
91,900
-7,108
-7% -$3.91M 0.11% 193
2022
Q1 		$58.5M Sell
99,008
-5,982
-6% -$3.44M 0.11% 183
2021
Q4 		$70.1M Buy
104,990
+231
+0.2% +$144K 0.13% 163
2021
Q3 		$59.9M Sell
104,759
-5,152
-5% -$2.83M 0.12% 174
2021
Q2 		$55.5M Buy
109,911
+6,944
+7% +$3.28M 0.11% 186
2021
Q1 		$47M Buy
102,967
+12,411
+14% +$5.92M 0.11% 199
2020
Q4 		$42.2M Buy
90,556
+2,737
+3% +$1.28M 0.11% 198
2020
Q3 		$38.8M Sell
87,819
-272
-0.3% -$112K 0.11% 197
2020
Q2 		$31.9M Buy
+88,091
New +$29.5M 0.1% 208
2020
Q1 		– Sell
-84,878
Closed -$27.6M – 2825
2019
Q4 		$27.6M Buy
84,878
+7,593
+10% +$2.3M 0.09% 241
2019
Q3 		$22.5M Buy
77,285
+6,791
+10% +$1.94M 0.08% 253
2019
Q2 		$20.7M Sell
70,494
-1,329
-2% -$366K 0.08% 267
2019
Q1 		$19.7M Buy
71,823
+5,230
+8% +$1.3M 0.08% 268
2018
Q4 		$14.9M Buy
66,593
+5,932
+10% +$1.39M 0.08% 272
2018
Q3 		$14.8M Buy
60,661
+7,687
+15% +$1.77M 0.07% 324
2018
Q2 		$11M Buy
+52,974
New +$11.2M 0.06% 358
2018
Q1 		– Sell
-40,784
Closed -$7.75M – 2723
2017
Q4 		$7.75M Buy
40,784
+2,542
+7% +$487K 0.05% 398
2017
Q3 		$7.24M Buy
38,242
+4,661
+14% +$844K 0.05% 420
2017
Q2 		$5.86M Buy
33,581
+2,920
+10% +$490K 0.04% 454
2017
Q1 		$4.71M Buy
30,661
+3,970
+15% +$607K 0.04% 505
2016
Q4 		$3.77M Sell
26,691
-414
-2% -$61K 0.03% 530
2016
Q3 		$4.31M Sell
27,105
-1,295
-5% -$200K 0.04% 487
2016
Q2 		$4.2M Sell
28,400
-435
-2% -$64.2K 0.04% 454
2016
Q1 		$4.08M Buy
28,835
+2,391
+9% +$320K 0.05% 392
2015
Q4 		$3.75M Sell
26,444
-4,541
-15% -$606K 0.04% 437
2015
Q3 		$3.79M Buy
+30,985
New +$4.04M 0.06% 346
2013
Q3 		– Sell
-12,715
Closed -$1.08M – 911
2013
Q2 		$1.08M Buy
+12,715
New +$1.06M 0.03% 595

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Raymond James Financial Services Advisors's TMO Position: Q3 2024 in Review

Raymond James Financial Services Advisors reduced its Thermo Fisher Scientific (TMO) stake by 6.4% in Q3 2024, selling an estimated $3.46M and leaving 86,208 shares worth $53.3M. The position accounts for 0.07% of the portfolio, ranked #265.

Raymond James Financial Services Advisors first reported a position in TMO in Q2 2013 and has held it in 36 quarters since. The position peaked at $70.1M in Q4 2021. 2,569 funds tracked by Wall St. Rank hold TMO as of Q3 2024.

  • Raymond James Financial Services Advisors held 86,208 shares of Thermo Fisher Scientific worth $53.3M as of Q3 2024.
  • Raymond James Financial Services Advisors sold 5,849 Thermo Fisher Scientific shares in Q3 2024, an estimated $3.46M.
  • Thermo Fisher Scientific made up 0.07% of Raymond James Financial Services Advisors's portfolio in Q3 2024, its #265 holding.
  • Raymond James Financial Services Advisors first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 36 quarters since.
  • Raymond James Financial Services Advisors's Thermo Fisher Scientific position peaked at $70.1M in Q4 2021.
  • 2,569 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2024.

Based on Raymond James Financial Services Advisors's 13F filing for Q3 2024, filed 18 Oct 2024.